151 related articles for article (PubMed ID: 3838893)
1. Studies on the inhibition of ferrochelatase by N-alkylated dicarboxylic porphyrins. Steric factors involved and evidence that the inhibition is reversible.
De Matteis F; Gibbs AH; Harvey C
Biochem J; 1985 Mar; 226(2):537-44. PubMed ID: 3838893
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins.
McCluskey SA; Whitney RA; Marks GS
Mol Pharmacol; 1989 Oct; 36(4):608-14. PubMed ID: 2811858
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of protohaem ferro-lyase by N-substituted porphyrins. Structural requirements for the inhibitory effect.
De Matteis F; Gibbs AH; Smith AG
Biochem J; 1980 Sep; 189(3):645-8. PubMed ID: 7213349
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of cytochrome P-450 and production of N-alkylated porphyrins caused in isolated hepatocytes by substituted dihydropyridines. Structural requirements for loss of haem and alkylation of the pyrrole nitrogen atom.
de Matteis F; Hollands C; Gibbs AH; de Sa N; Rizzardini M
FEBS Lett; 1982 Aug; 145(1):87-92. PubMed ID: 6897045
[No Abstract] [Full Text] [Related]
5. Ferrochelatase and N-alkylated porphyrins.
Cole SP; Marks GS
Mol Cell Biochem; 1984 Sep; 64(2):127-37. PubMed ID: 6390167
[TBL] [Abstract][Full Text] [Related]
6. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase.
McCluskey SA; Marks GS; Sutherland EP; Jacobsen N; Ortiz de Montellano PR
Mol Pharmacol; 1986 Oct; 30(4):352-7. PubMed ID: 3762522
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II.
Kimmett SM; Whitney RA; Marks GS
Mol Pharmacol; 1992 Aug; 42(2):307-10. PubMed ID: 1513328
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
McCluskey SA; Marks GS; Whitney RA; Ortiz de Montellano PR
Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143
[TBL] [Abstract][Full Text] [Related]
9. Bovine ferrochelatase. Kinetic analysis of inhibition by N-methylprotoporphyrin, manganese, and heme.
Dailey HA; Fleming JE
J Biol Chem; 1983 Oct; 258(19):11453-9. PubMed ID: 6688622
[TBL] [Abstract][Full Text] [Related]
10. 2,2-Dialkyl-1,2-dihydroquinolines: cytochrome P-450 catalyzed N-alkylporphyrin formation, ferrochelatase inhibition, and induction of 5-aminolevulinic acid synthase activity.
Lukton D; Mackie JE; Lee JS; Marks GS; Ortiz de Montellano PR
Chem Res Toxicol; 1988; 1(4):208-15. PubMed ID: 2979733
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protohaem ferro-lyase in experimental porphyria. Isolation and partial characterization of a modified porphyrin inhibitor.
De Matteis F; Gibbs AH; Tephly TR
Biochem J; 1980 Apr; 188(1):145-52. PubMed ID: 7406876
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatic ferrochelatase by the four isomers of N-methylprotoporphyrin IX.
Ortiz de Montellano PR; Kunze KL; Cole SP; Marks GS
Biochem Biophys Res Commun; 1980 Dec; 97(4):1436-42. PubMed ID: 6894236
[No Abstract] [Full Text] [Related]
13. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase.
Dailey HA; Smith A
Biochem J; 1984 Oct; 223(2):441-5. PubMed ID: 6497856
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of hepatic ferrochelatase by the isomers of N-ethylprotoporphyrin IX.
Ortiz de Montellano PR; Kunze KL; Cole SP; Marks GS
Biochem Biophys Res Commun; 1981 Nov; 103(2):581-6. PubMed ID: 7332558
[No Abstract] [Full Text] [Related]
15. Interaction of free porphyrins and metalloporphyrins with mouse ferrochelatase. A model for the active site of ferrochelatase.
Dailey HA; Jones CS; Karr SW
Biochim Biophys Acta; 1989 Nov; 999(1):7-11. PubMed ID: 2804139
[TBL] [Abstract][Full Text] [Related]
16. The use of N-methylprotoporphyrin dimethyl ester to inhibit ferrochelatase in Rhodopseudomonas sphaeroides and its effect in promoting biosynthesis of magnesium tetrapyrroles.
Houghton JD; Honeybourne CL; Smith KM; Tabba HD; Jones OT
Biochem J; 1982 Nov; 208(2):479-86. PubMed ID: 6984332
[TBL] [Abstract][Full Text] [Related]
17. Isolation of N-vinylprotoporphyrin IX after hepatic cytochrome P450 inactivation by 3-[(arylthio)ethyl]sydnone in chick embryos pretreated with phenobarbital, glutethimide, dexamethasone, and beta-naphthoflavone: differential inhibition of ferrochelatase by N-vinylprotoporphyrin regioisomers.
Kimmett SM; Whitney RA; Marks GS
Mol Pharmacol; 1996 Apr; 49(4):676-82. PubMed ID: 8609896
[TBL] [Abstract][Full Text] [Related]
18. Purification and substrate specificity of bovine liver-ferrochelatase.
Taketani S; Tokunaga R
Eur J Biochem; 1982 Oct; 127(3):443-7. PubMed ID: 7173190
[TBL] [Abstract][Full Text] [Related]
19. The importance of porphyrin distortions for the ferrochelatase reaction.
Sigfridsson E; Ryde U
J Biol Inorg Chem; 2003 Feb; 8(3):273-82. PubMed ID: 12589563
[TBL] [Abstract][Full Text] [Related]
20. Porphyrinogenic activity and ferrochelatase-inhibitory activity of sydnones in chick embryo liver cells.
Sutherland EP; Marks GS; Grab LA; Ortiz de Montellano PR
FEBS Lett; 1986 Mar; 197(1-2):17-20. PubMed ID: 3949013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
